APPROVe study follow-up confirms cardiovascular risk with rofecoxib

Most viewed articles this week

• Respiratory depression rare with rectal diazepam (06/06/2005)
• Cannabis effective in neuropathic pain (06/09/2010)
• Doctors shun help for depression (06/09/2010)
• Testing for aspirin resistance unlikely to be helpful in stroke prevention (06/09/2010)
• Lamotrigine, valproate trade-off in pregnancy (06/09/2010)

Recent comments

• Dr Peter Piazza said "I agree with Professor Nair that music needs to be individualised and targeted for a..."
• David said "Haydn, Stravinsky, Sibelius or Richard Strauss might have been better: they actually lived to become..."
• Jennifer Manson said "Hardly surprising as aside from the direct physiological impacts such as high cortisol, disturbed sleep..."
• David Hutchinson said "Should be OK if the patients starts on the generic and continues it. ..."
• Ernest Somerville said "I am glad you have highlighted our article. Just to clarify, we don't propose that..."

Related sites

• 6minutes
• Australian Doctor
• Cardiology Update
• Endocrinology Update
• Gastroenterology Update
• Oncology Update
• Pharmacy News
• Psychiatry Update
• Rheumatology Update